PMC:7408073 / 109211-109595 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":126,"end":130},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T225","span":{"begin":126,"end":130},"obj":"Body_part"}],"attributes":[{"id":"A225","pred":"uberon_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3701","span":{"begin":200,"end":204},"obj":"Gene"},{"id":"3702","span":{"begin":213,"end":217},"obj":"Gene"},{"id":"3703","span":{"begin":208,"end":212},"obj":"Gene"},{"id":"3704","span":{"begin":345,"end":353},"obj":"Species"},{"id":"3705","span":{"begin":75,"end":86},"obj":"Disease"},{"id":"3706","span":{"begin":106,"end":125},"obj":"Disease"},{"id":"3707","span":{"begin":143,"end":153},"obj":"Disease"},{"id":"3708","span":{"begin":308,"end":319},"obj":"Disease"},{"id":"3709","span":{"begin":355,"end":363},"obj":"Disease"}],"attributes":[{"id":"A3701","pred":"tao:has_database_id","subj":"3701","obj":"Gene:185"},{"id":"A3702","pred":"tao:has_database_id","subj":"3702","obj":"Gene:24182"},{"id":"A3703","pred":"tao:has_database_id","subj":"3703","obj":"Gene:116511"},{"id":"A3704","pred":"tao:has_database_id","subj":"3704","obj":"Tax:9606"},{"id":"A3705","pred":"tao:has_database_id","subj":"3705","obj":"MESH:D009461"},{"id":"A3706","pred":"tao:has_database_id","subj":"3706","obj":"MESH:D006331"},{"id":"A3707","pred":"tao:has_database_id","subj":"3707","obj":"MESH:D013927"},{"id":"A3708","pred":"tao:has_database_id","subj":"3708","obj":"MESH:D009461"},{"id":"A3709","pred":"tao:has_database_id","subj":"3709","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T595","span":{"begin":143,"end":153},"obj":"Disease"},{"id":"T596","span":{"begin":355,"end":363},"obj":"Disease"}],"attributes":[{"id":"A595","pred":"mondo_id","subj":"T595","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A596","pred":"mondo_id","subj":"T596","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T94","span":{"begin":126,"end":130},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T95","span":{"begin":126,"end":130},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T96","span":{"begin":179,"end":189},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T97","span":{"begin":367,"end":368},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T544","span":{"begin":0,"end":384},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Unfortunately, diseases of different aetiologies may present similar final dysfunction/alterations (e.g., cardiac dysfunction/lung alterations/thrombosis are induced by excessive activation of either AT1R or MasR/AT2R pathways, see Figure 1), while diseases with same aetiologies may present different final dysfunction/alterations depending on patients (COVID-19 is a clear example)."}